Moreover, the tumor’s consumption of glucose can limit its availability to T cells, reducing mTOR signaling, IFNγ production, and the glycolytic capacity of T cells, further dampening their anti-tumor activity (216). The gene discussed is IFNG; the disease is neoplasm.